Coagulopathy and the role of recombinant human activated protein C in sepsis and following polytrauma

Author： Dahabreh Ziad Dimitriou Rozalia Chalidis Byron Giannoudis Peter V

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.5, Iss.1, 2006-01, pp. : 67-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The epidemiology of severe sepsis syndrome and its treatment with recombinant human activated protein C

By Doig Christopher James Laupland Kevin B Zygun David A Manns Braden J

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1789-1799

Informa Healthcare

Access to resources Recommend Favorite

Activated protein C provides a new therapeutic option in sepsis

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

C-Reactive Protein: Interaction with the Vascular Endothelium and Possible Role in Human Atherosclerosis

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-01 ,pp. : 1631-1645

Bentham Science Publishers

Access to resources Recommend Favorite

Uncontrolled Bleeding in Surgical Patients: The Role of Recombinant Activated Factor VIIa

Current Drug Targets, Vol. 10, Iss. 8, 2009-08 ,pp. : 744-770

Bentham Science Publishers

Access to resources Recommend Favorite

Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation

By Ayelli Edgar V. Sterin-Borda L. Cremaschi G.A. Genaro A.M.

European Journal of Pharmacology, Vol. 372, Iss. 1, 1999-05 ,pp. : 65-73

Elsevier

Access to resources Recommend Favorite